These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15901345)

  • 1. A site-specific controlled-release system for metformin.
    Di Colo G; Zambito Y; Baggiani A; Carelli V; Serafini MF
    J Pharm Pharmacol; 2005 May; 57(5):565-71. PubMed ID: 15901345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of a system for pH-controlled peroral delivery of metformin.
    Di Colo G; Falchi S; Zambito Y
    J Control Release; 2002 Apr; 80(1-3):119-28. PubMed ID: 11943392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release matrix tablets of metformin hydrochloride in combination with triacetyl-beta-cyclodextrin.
    Corti G; Cirri M; Maestrelli F; Mennini N; Mura P
    Eur J Pharm Biopharm; 2008 Feb; 68(2):303-9. PubMed ID: 17616379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets.
    Ribeiro L; Ferreira DC; Veiga FJ
    J Control Release; 2005 Mar; 103(2):325-39. PubMed ID: 15763617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
    Bendas ER; Ayres JW
    Eur J Pharm Biopharm; 2008 Aug; 69(3):977-85. PubMed ID: 18424095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrices for site-specific controlled-delivery of 5-fluorouracil to descending colon.
    Zambito Y; Baggiani A; Carelli V; Serafini MF; Di Colo G
    J Control Release; 2005 Feb; 102(3):669-77. PubMed ID: 15681088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and development of hydrodynamically balanced system for metformin: in vitro and in vivo evaluation.
    Ali J; Arora S; Ahuja A; Babbar AK; Sharma RK; Khar RK; Baboota S
    Eur J Pharm Biopharm; 2007 Aug; 67(1):196-201. PubMed ID: 17270409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and in vitro testing of a floatable gastroretentive tablet of metformin hydrochloride.
    Basak SC; Rahman J; Ramalingam M
    Pharmazie; 2007 Feb; 62(2):145-8. PubMed ID: 17341036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma scintigraphic study of the hydrodynamically balanced matrix tablets of Metformin HCl in rabbits.
    Razavi M; Karimian H; Yeong CH; Sarji SA; Chung LY; Nyamathulla S; Noordin MI
    Drug Des Devel Ther; 2015; 9():3125-39. PubMed ID: 26124637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of quality control parameters and interchangeability of multisourced metformin HCl tablets marketed in Nigeria.
    Osadebe PO; Akabogu IC
    Boll Chim Farm; 2004 May; 143(4):170-3. PubMed ID: 15255340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-beta-cyclodextrin.
    Corti G; Capasso G; Maestrelli F; Cirri M; Mura P
    J Pharm Biomed Anal; 2007 Nov; 45(3):480-6. PubMed ID: 17822867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of compound metformin/glipizide elementary osmotic pump tablets.
    Ouyang D; Nie S; Li W; Guo H; Liu H; Pan W
    J Pharm Pharmacol; 2005 Jul; 57(7):817-20. PubMed ID: 15969939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
    Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M; Nokhodchi A
    Farmaco; 2005 Apr; 60(4):361-5. PubMed ID: 15848213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a robust once-a-day glipizide matrix system.
    Jamzad S; Fassihi R
    J Pharm Pharmacol; 2007 Jun; 59(6):769-75. PubMed ID: 17637169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of dissolution media pH and USP1 basket speed on erosion and disintegration characteristics of immediate release metformin hydrochloride tablets.
    Desai D; Wong B; Huang Y; Tang D; Hemenway J; Paruchuri S; Guo H; Hsieh D; Timmins P
    Pharm Dev Technol; 2015; 20(5):540-5. PubMed ID: 24621340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of highly porous gastroretentive metformin tablets using a sublimation method.
    Oh TO; Kim JY; Ha JM; Chi SC; Rhee YS; Park CW; Park ES
    Eur J Pharm Biopharm; 2013 Apr; 83(3):460-7. PubMed ID: 23246798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.